Shmuel Meitar

Founder at Zap Group Ltd.

Shmuel Meitar

Shmuel Meitar

Founder at Zap Group Ltd.

Overview
Career Highlights

Golden Channels & Co.
Zap Group Ltd.
enabley, Inc.

RelSci Relationships

630

Number of Boards

7

Birthday

1944

Age

77

Relationships
RelSci Relationships are individuals Shmuel Meitar likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Milken Family Foundation

Relationship likelihood: Strong

Founder at Heritage Provider Network, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Prostate Cancer Foundation

Relationship likelihood: Strong

Founder at Zap Group Ltd.

Relationship likelihood: Strong

Director-Project on International Order & Strategy & Senior Fellow-Foreign Policy, Center for East Asia Policy Studies & Center for Security, Strategy & Technology at The Brookings Institution

Relationship likelihood: Strong

Member, Board of Directors at Prostate Cancer Foundation

Relationship likelihood: Strong

Channel 2 Consumer Adviser at WSB - TV

Relationship likelihood: Strong

Faculty Member at Hertog Foundation, Inc.

Relationship likelihood: Strong

Chairman & Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at University of Texas - MD Anderson Cancer Center

Relationship likelihood: Strong

Vice President Revenue Cycle at Trinity Mother Frances Health System

Relationship likelihood: Strong

Paths to Shmuel Meitar
Potential Connections via
Relationship Science
You
Shmuel Meitar
Founder at Zap Group Ltd.
Career History
Founder
1968 - Current

Zap Group Ltd. engages in operation of content web platforms. It is providing a basket of marketing and publicity solutions adapted to small and medium-sized businesses in Israel, in various business segments. Amogn the group's websites are: zap rest, zap doctors, zap business, and Weekend. The company was founded by Morris Kahn and Shmuel Meitar in 1968 and is headquartered in Petah Tikva, Israel.

Founder
2004 - Prior

enabley, Inc. engages in the provision of end-to-end Ed-Tech solutions. Its SaaS training platform provides natural language processing technology, microlearning methods, and measurement algorithms. The company was founded in 2005 and is headquartered in New York, NY.

Founder
1968 - Prior

Aurec Ltd. is a private equity firm investing in media, communication and information companies. The company was founded in 1968 by Shmuel Meitar and is headquartered in Ramat Gan, Israel.

Boards & Committees
Director
1992 - ?

The Jerusalem Post is a private company headquartered in Israel that operates newspaper and news websites.

Director
Tenure Unconfirmed

Golden Pages Publications Ltd., part of Golden Pages Group Ltd., is a company headquartered in Ramat Gan, Israel. The firm publishes yellow pages and related web based search engines. On 29 Oct 04 Markstone Capital Partners LP acquired Golden Pages Publications Ltd. from Acrec Group for $111.70 million.

Member, Board of Directors
Current

FasterCures, a center of the Milken Institute, is an action tank, determined to remove barriers to medical progress. They have only one goal: to save lives as rapidly as possible. They work to improve the medical research system - so that They can speed up the time it takes to get important new medicines from discovery to patients.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$150K - $250K
2019

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

$10K - $15K
2018

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

$1,000 +
2017

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

Events
Speaker
Los Angeles, CA, United States
2013 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

Speaker
Los Angeles, CA, United States
2004 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Shmuel Meitar. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Shmuel Meitar's profile does not indicate a business or promotional relationship of any kind between RelSci and Shmuel Meitar.